Live feed07:00:00·15dPRReleasevia QuantisnowRedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug DesignationByQuantisnow·Wall Street's wire, on your screen.CPIX· Cumberland Pharmaceuticals Inc.RDHL· Redhill Biopharma Ltd.Health Care
